Literature DB >> 23352136

HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery.

Bainan Wu1, Ziming Zhang, Roberta Noberini, Elisa Barile, Marc Giulianotti, Clemencia Pinilla, Richard A Houghten, Elena B Pasquale, Maurizio Pellecchia.   

Abstract

Fragment-based ligand design (FBLD) approaches have become more widely used in drug discovery projects from both academia and industry, and are even often preferred to traditional high-throughput screening (HTS) of large collection of compounds (>10(5)). A key advantage of FBLD approaches is that these often rely on robust biophysical methods such as NMR spectroscopy for detection of ligand binding, hence are less prone to artifacts that too often plague the results from HTS campaigns. In this article, we introduce a screening strategy that takes advantage of both the robustness of protein NMR spectroscopy as the detection method, and the basic principles of combinatorial chemistry to enable the screening of large libraries of fragments (>10(5) compounds) preassembled on a common backbone. We used the method to identify compounds that target protein-protein interactions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352136      PMCID: PMC3966493          DOI: 10.1016/j.chembiol.2012.10.015

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  66 in total

1.  Structural biology. Controlling the caspases.

Authors:  S W Fesik; Y Shi
Journal:  Science       Date:  2001-11-16       Impact factor: 47.728

Review 2.  Screening in a spirit haunted world.

Authors:  Brian K Shoichet
Journal:  Drug Discov Today       Date:  2006-07       Impact factor: 7.851

3.  A high-throughput screen for aggregation-based inhibition in a large compound library.

Authors:  Brian Y Feng; Anton Simeonov; Ajit Jadhav; Kerim Babaoglu; James Inglese; Brian K Shoichet; Christopher P Austin
Journal:  J Med Chem       Date:  2007-04-21       Impact factor: 7.446

Review 4.  Fragment-based ligand discovery.

Authors:  Marcus Fischer; Roderick E Hubbard
Journal:  Mol Interv       Date:  2009-02

Review 5.  NMR methods in fragment screening: theory and a comparison with other biophysical techniques.

Authors:  Claudio Dalvit
Journal:  Drug Discov Today       Date:  2009-08-27       Impact factor: 7.851

6.  HTS promiscuity analyses for accelerating decision making.

Authors:  Alexander Böcker; Pierre R Bonneau; Paul J Edwards
Journal:  J Biomol Screen       Date:  2011-06-16

7.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

8.  Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.

Authors:  Haina Qin; Roberta Noberini; Xuelu Huan; Jiahai Shi; Elena B Pasquale; Jianxing Song
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

9.  PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.

Authors:  Roberta Noberini; Sayantan Mitra; Ombretta Salvucci; Fatima Valencia; Srinivas Duggineni; Natalie Prigozhina; Ke Wei; Giovanna Tosato; Ziwei Huang; Elena B Pasquale
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling.

Authors:  Thomas A Bowden; A Radu Aricescu; Joanne E Nettleship; Christian Siebold; Nahid Rahman-Huq; Raymond J Owens; David I Stuart; E Yvonne Jones
Journal:  Structure       Date:  2009-10-14       Impact factor: 5.006

View more
  29 in total

1.  2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine.

Authors:  Véronique Hamon; Raphael Bourgeas; Pierre Ducrot; Isabelle Theret; Laura Xuereb; Marie Jeanne Basse; Jean Michel Brunel; Sebastien Combes; Xavier Morelli; Philippe Roche
Journal:  J R Soc Interface       Date:  2013-11-06       Impact factor: 4.118

Review 2.  Biophysics in drug discovery: impact, challenges and opportunities.

Authors:  Jean-Paul Renaud; Chun-Wa Chung; U Helena Danielson; Ursula Egner; Michael Hennig; Roderick E Hubbard; Herbert Nar
Journal:  Nat Rev Drug Discov       Date:  2016-08-12       Impact factor: 84.694

3.  Protein-observed (19)F-NMR for fragment screening, affinity quantification and druggability assessment.

Authors:  Clifford T Gee; Keith E Arntson; Andrew K Urick; Neeraj K Mishra; Laura M L Hawk; Andrea J Wisniewski; William C K Pomerantz
Journal:  Nat Protoc       Date:  2016-07-14       Impact factor: 13.491

4.  HTS by NMR for the Identification of Potent and Selective Inhibitors of Metalloenzymes.

Authors:  Carlo Baggio; Linda Cerofolini; Marco Fragai; Claudio Luchinat; Maurizio Pellecchia
Journal:  ACS Med Chem Lett       Date:  2018-01-17       Impact factor: 4.345

Review 5.  A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.

Authors:  Kin-Hing William Lau; Matilda H-C Sheng
Journal:  Arch Biochem Biophys       Date:  2018-05-17       Impact factor: 4.013

Review 6.  Eph receptors and ephrins: therapeutic opportunities.

Authors:  Antonio Barquilla; Elena B Pasquale
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-03       Impact factor: 13.820

Review 7.  Advances in discovering small molecules to probe protein function in a systems context.

Authors:  Shelby K Doyle; Marius S Pop; Helen L Evans; Angela N Koehler
Journal:  Curr Opin Chem Biol       Date:  2015-11-23       Impact factor: 8.822

8.  High-Throughput Screening (HTS) by NMR Guided Identification of Novel Agents Targeting the Protein Docking Domain of YopH.

Authors:  Angel Bottini; Bainan Wu; Elisa Barile; Surya K De; Marilisa Leone; Maurizio Pellecchia
Journal:  ChemMedChem       Date:  2015-11-23       Impact factor: 3.466

Review 9.  Targeting the Eph System with Peptides and Peptide Conjugates.

Authors:  Stefan J Riedl; Elena B Pasquale
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 10.  Fragment-based drug discovery using NMR spectroscopy.

Authors:  Mary J Harner; Andreas O Frank; Stephen W Fesik
Journal:  J Biomol NMR       Date:  2013-05-18       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.